Tumors Metastatic to Brain Active Not Recruiting Phase 1 Trials for Ipilimumab (DB06186)

IndicationStatusPhase
DBCOND0029875 (Tumors Metastatic to Brain)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01703507Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for MelanomaTreatment